Skip to content

Balanced Salt Solution VS. Normal Saline Solution in Septic Shock

Balanced Salt Solution Versus Normal Saline Solution During Initial Resuscitation in Severe Sepsis or Septic Shock Children: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02336620
Enrollment
60
Registered
2015-01-13
Start date
2014-12-31
Completion date
2017-01-30
Last updated
2017-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock, Septic, Sepsis

Keywords

Severe sepsis, Balanced Salt Solution, Normal Saline

Brief summary

The Purpose of this study is to determine the impact of balanced salt solution versus chloride rich solution on clinical outcomes in paediatric severe sepsis or septic shock

Detailed description

The surviving sepsis campaign guideline recommended the isotonic crystalloids as the first choice of initial fluid resuscitation. The isotonic crystalloids are including chloride-rich solution (eg.NSS) and balanced salt solution. Retrospective study showed normal saline can induced hyperchloremic metabolic acidosis and acute kidney injury. However, no randomized controlled trial compare efficacy between the balanced salt solution and chloride rich solution.

Interventions

Ringer acetate 10-20 ml/kg IV bolus in 15-30 min,repeat bolus as needed by patient status

DRUGNormal saline

NSS 10-20 ml/kg IV bolus in 15-30 min,repeat bolus as needed by patient status

Sponsors

Ramathibodi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* children younger than 18 year old who has severe sepsis or septic shock * inform consent

Exclusion criteria

* children who had shock from other aetiologies * end stage disease or severe congenital anomaly * refuse to inform consent

Design outcomes

Primary

MeasureTime frame
incidence of hyperchloremic metabolic acidosis48 hour

Secondary

MeasureTime frame
28 day and 90 day mortality rate28 days and 90 days

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026